Upperton upping spray-dry production in $2m relocation

By Staff Reporter

- Last updated on GMT

GettyImages/Bablab
GettyImages/Bablab
Spray-drying service provider Upperton Pharma Solutions has expaned to offer GMP manufacturing for early-stage clinical trials.

The Nottingham, UK-based firm has completed a £1.5m ($2m) expansion to a larger, self-contained facility in order to increase its offering to include a range of new production services.

According to CEO Richard Johnson, the expansion was both driven by demand from clients and a strategic necessity for the company.

“We realise as a business that we need to offer this service to our customers in order to support continued growth,”​ he told this publication.

The 15,000 sq ft facility will house R&D, quality assurance and manufacturing departments, with the latter planned to be MHRA validated for clinical trials manufacturing by the third quarter this year.

It will also focus on dry powder formulations for capsules, tablets (oral dosage forms) and pulmonary and nasal devices, he said, focused on Phase I and II clinical trial supply.

Core equipment will be a Niro PSD-1 and ProCePT scale spray dryers with associated powder handling and dosage form development capabilities, with the larger spray dryer able to make batch sizes of several kilograms of spray dried powder.

Related products

show more

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Roquette Oral Dose Case Study - Part IV

Roquette Oral Dose Case Study - Part IV

Roquette Pharma Solutions | 04-Dec-2017 | Case Study

Download the latest Roquette case study and learn more on how PEARLITOL® Flash mannitol and starch compound offers inert stability, fast disintegration...

Roquette Oral Dose Case Study - Part III

Roquette Oral Dose Case Study - Part III

Roquette Pharma Solutions | 27-Nov-2017 | Case Study

Download the Case Study to find out how Roquette’s SweetPearl® P 300 DC maltitol technology makes an effervescent tablet solution attractive and palatable...

Roquette Oral Dose Case Study - Part II

Roquette Oral Dose Case Study - Part II

Roquette Pharma Solutions | 06-Nov-2017 | Case Study

Download the case study and learn more on how Roquette’s taste masking technology KLEPTOSE® Linecaps (KL) allows the delivery of an efficient taste masking...

Related suppliers